Publication | Open Access
Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus
56
Citations
33
References
2022
Year
This study provides Class IV evidence on the therapeutic utility of ketamine for treatment of RSE in children and neonates.
| Year | Citations | |
|---|---|---|
Page 1
Page 1